{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:18:33Z","timestamp":1769102313623,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00380-016-0879-x","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T02:23:55Z","timestamp":1469672635000},"page":"333-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices"],"prefix":"10.1007","volume":"32","author":[{"given":"Kohei","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Kamakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikutaro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Kamakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"879_CR1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.hrthm.2012.07.025","volume":"9","author":"JC Daubert","year":"2012","unstructured":"Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF, Breithard O, Brignole M, Cleland J, Delurgio DB, Dickstein K, Exner DV, Gold M, Grimm RA, Hayes DL, Israel C, Leclercq C, Linde C, Lindenfeld J, Merkely B, Mont L, Murgatroyd F, Prinzen F, Saba SF, Shinbane JS, Singh J, Tang AS, Vardas PE, Wilkoff BL, Zamorano JL (2012) 2012 EHRA\/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm 9:1524\u20131576","journal-title":"Heart Rhythm"},{"key":"879_CR2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4065\/81.5.641","volume":"81","author":"GW Stone","year":"2006","unstructured":"Stone GW, Aronow HD (2006) Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy. Mayo Clin Proc 81:641\u2013652","journal-title":"Mayo Clin Proc"},{"key":"879_CR3","doi-asserted-by":"crossref","first-page":"576s","DOI":"10.1378\/chest.126.3_suppl.576S","volume":"126","author":"JJ Popma","year":"2004","unstructured":"Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI (2004) Antithrombotic therapy during percutaneous coronary intervention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:576s\u2013599s","journal-title":"Chest"},{"key":"879_CR4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00380-013-0399-x","volume":"29","author":"SY Suh","year":"2014","unstructured":"Suh SY, Kang WC, Oh PC, Choi H, Moon CI, Lee K, Han SH, Ahn T, Choi IS, Shin EK (2014) Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation. Heart Vessels 29:578\u2013583","journal-title":"Heart Vessels"},{"key":"879_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0719-4","author":"Y Hamatani","year":"2015","unstructured":"Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2015) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels. doi: 10.1007\/s00380-015-0719-4","journal-title":"Heart Vessels"},{"key":"879_CR6","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 368:2084\u20132093","journal-title":"N Engl J Med"},{"key":"879_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2012.12.046","volume":"111","author":"CP Rowley","year":"2013","unstructured":"Rowley CP, Bernard ML, Brabham WW, Netzler PC, Sidney DS, Cuoco F, Sturdivant JL, Leman RB, Wharton JM, Gold MR (2013) Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol 111:1165\u20131168","journal-title":"Am J Cardiol"},{"key":"879_CR8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/europace\/eut423","volume":"16","author":"J Kosiuk","year":"2014","unstructured":"Kosiuk J, Koutalas E, Doering M, Sommer P, Rolf S, Breithardt OA, Nedios S, Dinov B, Hindricks G, Richter S, Bollmann A (2014) Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations. Europace 16:1028\u20131032","journal-title":"Europace"},{"key":"879_CR9","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1253\/circj.CJ-14-0665","volume":"78","author":"J Kosiuk","year":"2014","unstructured":"Kosiuk J, Koutalas E, Doering M, Nedios S, Sommer P, Rolf S, Darma A, Breithardt OA, Dinov B, Hindricks G, Richter S, Bollmann A (2014) Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case\u2013control study. Circ J 78:2402\u20132407","journal-title":". Circ J"},{"key":"879_CR10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/europace\/euu357","volume":"17","author":"V Zac\u00e0","year":"2015","unstructured":"Zac\u00e0 V, Marcucci R, Parodi G, Limbruno U, Notarstefano P, Pieragnoli P, Di Cori A, Bongiorni MG, Casolo G (2015) Management of antithrombotic therapy in patients undergoing electrophysiological device surgery. Europace 17:840\u2013854","journal-title":"Europace"},{"key":"879_CR11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","volume":"17","author":"C Sticherling","year":"2015","unstructured":"Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GYH (2015) Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 17:1197\u20131214","journal-title":"Europace"},{"key":"879_CR12","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","volume":"35","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Windecker S, Huber K, Kirchhof P, Marin F, TenBerg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D (2014) Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 35:3155\u20133179","journal-title":"Eur Heart J"},{"key":"879_CR13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/europace\/euu369","volume":"17","author":"X Yang","year":"2015","unstructured":"Yang X, Wang Z, Zhang Y, Yin X, Hou Y (2015) The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis. Europace 17:1076\u20131084","journal-title":"Europace"},{"key":"879_CR14","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864\u20132870","journal-title":"JAMA"},{"key":"879_CR15","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747","journal-title":"Eur Heart J"},{"key":"879_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GY Lip","year":"2011","unstructured":"Lip GY, Frison L, Halperin JL, Lane DA (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J Am Coll Cardiol 57:173\u2013180","journal-title":"J Am Coll Cardiol"},{"key":"879_CR17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","volume":"126","author":"DA Lane","year":"2012","unstructured":"Lane DA, Lip GY (2012) Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation 126:860\u2013865","journal-title":"Circulation"},{"key":"879_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"879_CR19","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R, American Collegeof Chest Physicians (2012) Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e326S\u2013e350S","journal-title":"Chest"},{"key":"879_CR20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1538-7836.2008.03080.x","volume":"6","author":"E Jamula","year":"2008","unstructured":"Jamula E, Douketis JD, Schulman S (2008) Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost 6:1615\u20131621","journal-title":"J Thromb Haemost"},{"key":"879_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1460-9592.2003.00084.x","volume":"26","author":"AS Al-Khadra","year":"2003","unstructured":"Al-Khadra AS (2003) Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 26:511\u2013514","journal-title":"Pacing Clin Electrophysiol"},{"key":"879_CR22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2004.00441.x","volume":"27","author":"MC Giudici","year":"2004","unstructured":"Giudici MC, Paul DL, Bontu P, Barold SS (2004) Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 27:358\u2013360","journal-title":"Pacing Clin Electrophysiol"},{"key":"879_CR23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1540-8159.1998.tb00271.x","volume":"21","author":"DJ Goldstein","year":"1998","unstructured":"Goldstein DJ, Losquadro W, Spotnitz HM (1998) Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 21:1730\u20131734","journal-title":"Pacing Clin Electrophysiol"},{"key":"879_CR24","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2009.12.056","volume":"55","author":"C Tompkins","year":"2010","unstructured":"Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA (2010) Dual antiplatelet therapy and heparin \u201cbridging\u201d significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 55:2376\u20132382","journal-title":"J Am Coll Cardiol"},{"key":"879_CR25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/europace\/eur210","volume":"13","author":"P Korantzopoulos","year":"2011","unstructured":"Korantzopoulos P, Letsas KP, Liu T, Fragakis N, Efremidis M, Goudevenos JA (2011) Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices. Europace 13:1669\u20131680","journal-title":"Europace"},{"key":"879_CR26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.126.4.1177","volume":"126","author":"UK Wiegand","year":"2004","unstructured":"Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet\/anticoagulation therapy. Chest 126:1177\u20131186","journal-title":"Chest"},{"key":"879_CR27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.106.678664","volume":"116","author":"D Klug","year":"2007","unstructured":"Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116:1349\u20131355","journal-title":"Circulation"},{"key":"879_CR28","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","volume":"35","author":"G Breithardt","year":"2014","unstructured":"Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, ROCKETAF Steering Committee Investigators (2014) Clinical characteristics and outcome with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J 35:3377\u20133385","journal-title":"Eur Heart J"},{"key":"879_CR29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.51.3.674","volume":"51","author":"RG Hart","year":"1998","unstructured":"Hart RG, Sherman DG, Easton JD, Cairns JA (1998) Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51:674\u2013681","journal-title":"Neurology"},{"key":"879_CR30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","volume":"335","author":"EM Hylek","year":"1996","unstructured":"Hylek EM, Skates SJ, Sheehan MA, Singer DE (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335:540\u2013546","journal-title":"N Engl J Med"},{"key":"879_CR31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","volume":"50","author":"AY Shen","year":"2007","unstructured":"Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W (2007) Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50:309\u2013315","journal-title":"J Am Coll Cardiol"},{"key":"879_CR32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.40.1183","volume":"40","author":"M Yasaka","year":"2001","unstructured":"Yasaka M, Minematsu K, Yamaguchi T (2001) Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40:1183\u20131188","journal-title":"Intern Med"},{"key":"879_CR33","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","volume":"78","author":"H Inoue","year":"2014","unstructured":"Inoue H, Atarashi H, Kamakura S, Koretsune Y, Kumagai K, Mitamura H, Okumura K, Sugi K, Yamashita T, Yasaka M, Satomi K, Kodama I, Ogawa S, Ohe T, Tsutsui H (2014) Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J 78:1997\u20132021","journal-title":"Circ J"},{"key":"879_CR34","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1253\/circj.CJ-13-0290","volume":"77","author":"JCS Joint Working Group","year":"2013","unstructured":"JCS Joint Working Group (2013) Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry. Circ J 77:2264\u20132270","journal-title":"Circ J"},{"key":"879_CR35","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/eurheartj\/ehp194","volume":"30","author":"JM Tolosana","year":"2009","unstructured":"Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J, Tamborero D, Benito B, Brugada J (2009) Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 30:1880\u20131884","journal-title":"Eur Heart J"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-016-0879-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0879-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:23:08Z","timestamp":1498317788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-016-0879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s00380-016-0879-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}